Atlas Trials

Lumos Pharma

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Lumos Pharma

RecordFirmDate
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adults (NCT07754045)Lumos Pharma2027-02-15
Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency (NCT07129759)Lumos Pharma2027-02-01
Trial of NLG802 Indoximod Prodrug Plus Temozolomide for Patients With Progressive Pediatric Brain Cancer (NCT07732413)Lumos Pharma2026-10-08
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency (NCT06948214)Lumos Pharma2026-05-20
A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211) (NCT05796440)Lumos Pharma2023-08-01
Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213) (NCT05250063)Lumos Pharma2022-02-18
PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212) (NCT04806854)Lumos Pharma2021-07-14
Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) (NCT04614337)Lumos Pharma2020-12-31

Track Lumos Pharma automatically

Every clearance here is in the API, with alerts when new ones post.